{"transactions":[{"id":2647810,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T16:19:46.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":7.44,"exercise_date":"2022-06-30","expiration_date":"2031-06-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-044380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919121044380/doc4.xml","form_type":"4"}},{"id":2848635,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T19:04:31.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":23591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in full on February 3, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired."}],"balance_after":23591,"derivative":{"exercise_price":25,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":23591},"source":{"system":"sec-edgar","filing":"0000899243-21-007199","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768286/000089924321007199/doc4a.xml","form_type":"4/A","original_submission_date":"2021-02-05"}},{"id":2868379,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2021-02-10T18:52:55.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":366122,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by the Geoffrey A. von Malzahn 2020 GRAT"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":366122},"source":{"system":"sec-edgar","filing":"0000899243-21-005736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1768286/000089924321005736/doc4.xml","form_type":"4"}},{"id":2868378,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2021-02-10T18:52:55.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":1464488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1464488},"source":{"system":"sec-edgar","filing":"0000899243-21-005736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1768286/000089924321005736/doc4.xml","form_type":"4"}},{"id":2868377,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-10T18:52:55.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":366122,"ownership":{"direct":false,"nature":"Held by the Geoffrey A. von Malzahn 2020 GRAT"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."}],"balance_after":366122,"source":{"system":"sec-edgar","filing":"0000899243-21-005736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1768286/000089924321005736/doc4.xml","form_type":"4"}},{"id":2868376,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-10T18:52:55.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":1464488,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering."}],"balance_after":1464488,"source":{"system":"sec-edgar","filing":"0000899243-21-005736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768286/000089924321005736/doc4.xml","form_type":"4"}},{"id":2876234,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-05T17:22:18.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on February 3, 2022."}],"balance_after":14000,"derivative":{"exercise_price":25,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000899243-21-005083","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768286/000089924321005083/doc4.xml","form_type":"4"}},{"id":3095410,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-01T16:16:53.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":7.43,"exercise_date":"2021-06-30","expiration_date":"2030-06-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-039729","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919120039729/doc4.xml","form_type":"4"}},{"id":3619520,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-03-04T20:09:54.000Z","date":"2019-03-04","kind":"exercise","acquired":false,"shares":684932,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":342466},"source":{"system":"sec-edgar","filing":"0000899243-19-005957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319005957/doc4.xml","form_type":"4"}},{"id":3619519,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":137686,"kind":"person","name":"von Maltzahn Geoffrey","position":1,"cik":"0001768286","reported_name":"von Maltzahn Geoffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-04T20:09:54.000Z","date":"2019-03-04","kind":"exercise","acquired":true,"shares":342466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.001 (\"Common Stock\"), on a one-for-two basis upon the closing of the Issuer's initial public offering."}],"balance_after":342466,"source":{"system":"sec-edgar","filing":"0000899243-19-005957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000089924319005957/doc4.xml","form_type":"4"}}]}